Local delivery of chlorhexidine gluconate (PerioChipTM) in periodontal maintenance patients
Authors:
- P. A. HeasmanPHP. A. Heasman
- L. HeasmanLHL. Heasman
- F. StaceyFSF. Stacey
- G. I. McCrackenGMG. I. McCracken
- 1 January 2001
- journal article
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 28 (1) , 90-95
Abstract
The aim of this randomised, split-mouth, single-blind study was to determine the efficacy of controlled-release delivery of chlorhexidine gluconate 2.5 mg (PerioChip) in patients with residual bleeding pockets (>5 mm) at least 3 months following oral hygiene and root debridement phase therapy. 26 patients (non-smokers) were screened and potential study sites identified. Clinical parameters recorded at baseline and all subsequent visits were plaque index (PI), pocket probing depth (PPD), bleeding index (BI) and clinical attachment level (CAL). All study sites were debrided using ultrasonic instrumentation. PerioChips (PC) were placed in the selected sites of two quadrants (left or right) whilst identified sites in the remaining quadrants were left without adjunctive antimicrobial treatment. Clinical measurements were made at follow-up visits after 1, 3 and 6 months. Mean changes from baseline in PPD, BI and CAL were calculated with the patient as the experimental unit and comparability between the treatments was determined using t-tests. At baseline there were no significant differences between PC and control sites for mean PI, PD, BI or CAL. The mean (SE) reductions in PPD for PC and control treatments were: 0.47 (0.1), 0.46 (0.1); 0.76 (0.1), 0.55 (0.1); 0.78 (0.1), 0.45 (0.1) for months 1, 3 and 6 respectively. Only at month 6 did the difference between treatments approach statistical significance (p=0.06). Mean (SE) reductions in CAL over the same periods were: 0.17 (0.1), 0.04 (0.08); 0.38 (0.1), 0.21 (0.1); 0.43 (0.1), 0.15 (0.09) p=0.048. Mean (SE) reduction in BI between PC and control treatments only reached statistical significance at 6 months: 1.08 (0.1), 0.59 (0.1) p=0.05. These data suggest that PerioChip is beneficial for patients on maintenance therapy although the benefit is not apparent until 6 months after placement.Keywords
This publication has 12 references indexed in Scilit:
- Comparative antiplaque effectiveness of an essential oil and an amine fluoride/stannous fluoride mouthrinseJournal of Clinical Periodontology, 1999
- A Six‐Month Comparison of Three Periodontal Local Antimicrobial Therapies in Persistent Periodontal PocketsJournal of Periodontology, 1999
- An in vivo Study of the chlorhexidine release profile of the PerioChipTM in the gingival crevicular fluid, plasma and urineJournal of Clinical Periodontology, 1998
- Local Metronidazole Application in Maintenance Patients. Clinical and Microbiological EvaluationJournal of Periodontology, 1998
- Adjunctive Use of a Subgingival Controlled‐Release Chlorhexidine Chip Reduces Probing Depth and Improves Attachment Level Compared With Scaling and Root Planing AloneJournal of Periodontology, 1998
- Topical metronidazole application in recall patientsJournal of Clinical Periodontology, 1997
- Sustained Local Delivery of Chlorhexidine in the Treatment of Periodontitis: A Multi‐Center StudyJournal of Periodontology, 1997
- Clinical responses to subgingival application of a metronidazole 25% gel compared to the effect of subgingival scaling in adult periodontitisJournal of Clinical Periodontology, 1992
- The in vitro effects of chlorhexidine on subgingival plaque bacteriaJournal of Clinical Periodontology, 1989
- Periodontal Disease in Pregnancy II. Correlation Between Oral Hygiene and Periodontal ConditionActa Odontologica Scandinavica, 1964